Abstract | BACKGROUND: Oxidative stress plays an important role in the pathogenesis of chronic liver diseases. The plasma level of 8-isoprostane, a product of lipid peroxidation, is a marker of oxidative stress in vivo. The aim of the present study was to clarify whether the degree of lipid peroxidation, as measured by the plasma level of 8-isoprostane, influences the progression of chronic liver diseases and hepatocarcinogenesis. METHODS: RESULTS: Plasma 8-isoprostane was significantly elevated in NAFLD (11.9 [3.8-56.8] pg/mL), CH-C (10.1 [4.2-134.5] pg/mL) as compared to controls (6.3 [3.6-11.1] pg/mL). Plasma 8-isoprostane values were positively correlated with body mass index in NAFLD (P < 0.05) and with total cholesterol in cured CH-C (P < 0.01). 8-Isoprostane levels were not significantly related to sex, age, biochemical data or iron metabolism markers in all liver diseases. In addition, after the administration of peg- interferon, the values of 8-isoprostane improved in almost all patients, reaching values of healthy subjects. CONCLUSIONS:
8-Isoprostane values are elevated in patients with NAFLD and CH-C as compared to healthy controls. Oxidative stress caused by increased lipid peroxidation is involved in the pathogenesis of NAFLD and CH-C.
|
Authors | Masayoshi Konishi, Motoh Iwasa, Jun Araki, Yoshinao Kobayashi, Akira Katsuki, Yasuhiro Sumida, Naoki Nakagawa, Yuji Kojima, Shozo Watanabe, Yukihiko Adachi, Masahiko Kaito |
Journal | Journal of gastroenterology and hepatology
(J Gastroenterol Hepatol)
Vol. 21
Issue 12
Pg. 1821-5
(Dec 2006)
ISSN: 0815-9319 [Print] Australia |
PMID | 17074020
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Biomarkers
- Drug Carriers
- Interferon alpha-2
- Interferon-alpha
- Recombinant Proteins
- 8-epi-prostaglandin F2alpha
- Polyethylene Glycols
- Dinoprost
- peginterferon alfa-2a
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents
(therapeutic use)
- Biomarkers
(blood)
- Dinoprost
(analogs & derivatives, blood)
- Disease Progression
- Drug Carriers
- Fatty Liver
(blood, pathology)
- Female
- Hepatitis C, Chronic
(blood, drug therapy, pathology)
- Humans
- Immunoenzyme Techniques
- Interferon alpha-2
- Interferon-alpha
(therapeutic use)
- Lipid Peroxidation
(physiology)
- Male
- Middle Aged
- Polyethylene Glycols
(therapeutic use)
- Prognosis
- Recombinant Proteins
|